In a new study, Nobel laureate David Baker and colleagues detail new methods for targeting undruggable "disordered" proteins.

While AI has already reshaped various industries, its impact on infrastructure and database management is only beginning to ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Modernizing legacy data systems is no longer optional—it's the key to unlocking AI’s full potential with real-time insights, ...